Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOPAS-1: Clopidogrel Pharmacodynamics in Stent Thrombosis
NCT00914368Phase 2Completed
- Sponsor
- Uppsala University
- Start
- Jan 2009
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of clopidogrel in coronary artery disease (CAD) (3 arms), sponsored by Uppsala University. Primary endpoint: VerifyNow P2Y12 Assay (PRU). Started Jan 2009; status: completed.
02
Drugs
clopidogrel
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00914368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00914368.